Lobomycosis: a therapeutic challenge

AUTOR(ES)

Araújo, Marcelo Grossi, Cirilo, Nathalie Silva, Santos, Soraya Neves Marques Barbosa dos, Aguilar, Claudemir Roberto, Guedes, Antonio Carlos Martins

FONTE

An. Bras. Dermatol.

DATA DE PUBLICAÇÃO

2018-03

RESUMO

Abstract: Lobomycosis or lacaziosis is a chronic granulomatous fungal infection caused by Lacazia loboi. Most cases are restricted to tropical regions. Transmission is believed to occur through traumatic inoculation in the skin, mainly in exposed areas. It is characterized by keloid-like nodules. There are only a few hundred cases reported. The differential diagnoses include many skin conditions, and treatment is difficult. The reported case, initially diagnosed as keloid, proved to be refractory to surgical treatment alone. It was subsequently approached with extensive surgery, cryotherapy every three months and a combination of itraconazole and clofazimine for two years. No signs of clinical and histopathological activity were detected during follow-up.

Documentos Relacionados

• Morbihan disease: a therapeutic challenge
• Erosive lichen planus: a therapeutic challenge
• American tegumentary leishmaniasis - a case of therapeutic challenge
• The diversity of endothelial cells: a challenge for therapeutic angiogenesis
• Frontal fibrosing alopecia and lichen planus pigmentosus: diagnosis and therapeutic challenge